Abstract
Of the several types of antibodies described in autoimmune disorders, the antiphospholipid antibodies have received relatively little attention. There are two well-described groups of antiphospholipid antibodies, anticardiolipin antibodies (Pangborn, 1941; De Bruijn, 1966; Inoue and Nojima, 1969; Harris et al., 1983, 1985c) and the lupus anticoagulant (Conley and Hartmann, 1952; Margolius et al., 1961; Feinstein and Rapaport, 1972; Veltkamp et al1974; Byron, 1982; Shapiro and Thiagarajan, 1982). Based on the demonstration of cross reactivity of some monoclonal DNA antibodies with cardiolipin and other phospholipids (Lafer et al., 1981; Schoenfeld et al., 1983; Koike et al., 1984a,b), it is believed by some investigators that a subgroup of anti-DNA antibodies may bind to the repeating phosphodiester groups on the polynucleotide backbone of DNA and that these antibodies, too, may be antiphospholipid antibodies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aggeler, P. M., Lindsay, S., and Lucia, S. P., 1946, Studies on the coagulation defect in a case of thrombocytopenic purpura complicated by thrombosis, Am. J. Pathol. 22: 1181–1203.
Aho, K., 1968, Studies of syphilitic antibodies, Br. J. Verier. Dis. 44: 283–286.
Alving, C., 1977, Immune reactions of lipids and lipid model membranes, in: The Antigens, Vol. 4 ( M. Sela, ed.), Academic Press, New York, pp. 1–56.
Angeles-Cano, E., Sultan, Y., and Clauvel, J. P., 1979, Predisposing factors to thrombosis in systemic lupus erythematosus: Possible relation to endothelial cell damage, J. Lab. Clin. Med. 94: 315–323.
Berglund, S., and Carlsson, M., 1966, Clinical significance of chronic biologic false postive Wasserman reaction and “antinuclear factors,” Acta. Med. Scand. 180: 407–412.
Bluestein, H. G., 1978, Neurocytotoxic antibodies in serum of patients with systemic lupus erythematosus, Proc. Natl. Acad. Sci. U.S.A. 75: 3965–3969.
Bluestein, H. G., and Zvaifler, N. J., 1976, Brain reactive lymphocytoxic antibodies in the serum of patients with systemic lupus erythematosus. J. Clin Invest. 57: 509–516.
Boey, M. L., Colaco, C. B., Gharavi, A. E., Elkon, K. B., Loizou, S., and Hughes, G. R. V., 1983, Thrombosis in SLE: Striking association with the presence of circulating “lupus anticoagulant,” Br. Med. J. 287: 1021–1023.
Bowie, W. E. J., Thompson, J. H., Pascuzzi, C. A., and Owen, C. A., 1963, Thrombosis in systemic lupus erythematosus despite circulating anticoagulants, J. Clin. Invest. 62: 416–430.
Boxer, M., Ellman, L., and Carvalho, A., 1976, The lupus anticoagulant, Arthritis Rheum. 19: 1244–1248.
Bresnihan, B., Oliver, M., Grigor, G., and Hughes, G. R. V., 1977, Brain reactivity of lymphocytotoxic antibodies in systemic lupus erythematosus with and without cerebral involvement, Clin. Exp. Immunol. 30: 333–337.
Bresnihan, B., Oliver, M., Williams, B., and Hughes, G. R. V., 1979, An antineuronal antibody cross-reactive with erythrocytes and lymphocytes in systemic lupus erythematosus, Arthritis Rheum. 22: 313–320.
Byron, M. A., 1982, The clotting defect in SLE, Clin. Rheum. Dis. 8: 137–151.
Canoso, R. T., and Sise, H. S., 1982, Chlorpromazine-induced lupus anticoagulant and associated immunologic abnormalities, Am. J. Hematol. 13: 121–129.
Carreras, L. O., and Vermelyn, J. G., 1982, “Lupus” anticoagulant and thrombosis—possible role of inhibition of prostacyclin formation, Thromb. Haemostas. (Stuttgart) 48: 38–40.
Carreras, L. O., Defreyn, G., and Machin, S. J., 1981, Arterial thrombosis, intrauterine death and lupus anticoagulant: Detection of immunoglobulin interfering with prostacyclin formation, Lancet 1: 244–246.
Catterall, R. D., 1973, Biological false positive reactions and systemic disease, in: Ninth Symposium on Advanced Medicine ( G. Walker, ed.), Pitman Medical, London, pp. 97–111.
Conley, C. L., and Hartmann, R. C., 1952, A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus, J. Clin. Invest. 31: 621–622.
Cooper, M. R., Cohen, H. J., Huntley, C. C., Waite, B. M., Spees, L., and Spurr, L., 1974, A monoclonal IgM with antibodylike specificity for phospholipids in a patient with lymphoma, Blood 43: 493–504.
Coots, M. C., Miller, M. A., and Glueck, H. I., 1981, The lupus inhibitor. A study of its heterogeneity, Thromb. Haemostas. 46: 734–739.
De Bruijn, J. H., 1966, Chemical structure and serological activity of natural and synthetic cardiolipin and related compounds, Br. J. Vener. Dis. 42: 125–128.
De Siervo, A. J., 1974, Anti-cardiolipin and anti-phosphatidylglycerol antibodies prepared against bacterial phospholipids, Infect. Immun. 9: 835–838.
Editorial, 1984, Lupus anticoagulant, Lancet 1: 1157–1158.
Elias, M., and Eldor, A., 1984, Thromboembolism in patients with the 4 lupus’-like circulating anticoagulant, Arch. Intern. Med. 144: 510–515.
Exner, T., Rickard, K. A., and Kronenberg, H., 1975, Studies on phospholipids in the action of a lupus coagulation inhibitor, Pathology 7: 319–328.
Exner, T., Rickard, K. A., and Kronenberg, H., 1978, A sensitive test demonstrating lupus anticoagulant and its behavioural patterns, Br. J. Haematol. 40: 143–151.
Exner, T., Barber, S., Kronenberg, H., and Rickard, K., 1980, Familial association of the lupus anticoagulant, Br. J. Haematol. 45: 89–96.
Faure, M., and Coulon-Morelec, M., 1963, Entre la structure chimique du cardiolipide et son activite sero- logique. Conservation du cardiolipide, Ann. Inst. Pasteur (Paris) 104: 246–263.
Feinstein, D. I., and Rapaport, S. I., 1972, Acquired inhibitors of blood coagulation, in: Progress in Hemostasis and Thrombosis, Vol. 1 ( T. N. Spaet, ed.), Grune & Stratton, New York, pp. 79–95.
Firkin, B. G., Booth, P., Hendrix, L., and Howard, M. A., 1978, Demonstration of a platelet by-pass mechanism in the clotting system using an acquired anticoagulant, Am. J. Hematol. 5: 81–92.
Firkin, B. G., Howard, M. A., and Radford, N., 1980, Possible relationship between lupus inhibitor and recurrent abortion in young women, Lancet 2: 366.
Fiumara, N. S., 1963, Biologic false-positive reaction for syphilis, N. Engl. J. Med. 268: 402–405.
Fowler, E., and Allen, R. H., 1962, Studies on the production of Wasserman reagin, J. Immunol. 88: 591–594.
Frick, P. G., 1955, Acquired circulating anticoagulants in systemic “collagen disease”: Autoimmune throm-boplastin deficiency, Blood 10: 691–706.
Fulford, K. W., Catterrall, R. D., Delhanty, J. J., Donjach, V., and Kremer, M., 1972, A collagen disorder of the nervous system presenting as multiple sclerosis, Brain 95: 373–386.
Gladman, D. D., Urowitz, M. B., Tozman, E. C., and Glynn, M. X., 1983, Haemostatic abnormalities in systemic lupus erythematosus, Q. J. Med. 207: 424–433.
Gonyea, L., Herdman, R., and Bridges, R. A., 1968, The coagulation abnormalities in systemic lupus ery-thematosus, Thromb. Diathes. Haemorrh. 20: 457–464.
Gray, G. M., and MacFarlane, M. G., 1958, Separation and composition of the phospholipids of ox heart, Biochem. J. 70: 409–433.
Guarnieri, M., 1974, Reaction of cardiolipin and phosphatidylinositol antisera with phospholipids antigens, Lipids 9: 692–695.
Guarnieri, M., 1975, Reaction of anti-phosphatidyl inositol antisera with neural membrane, Lipids 10: 294–298.
Guarneiri, M., and Eisner, D., 1974, A DNA antigen that reacts with antisera to cardiolipin, Biochem. Biophys. Res. Commun. 58: 347–353.
Harris, E. N., Gharavi, A. E., Boey, M. L., Patel, B. M., Mackworth-Young, C. G., Loizou, S., and Hughes, G. R. V., 1983, Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus, Lancet 2: 1211–1214.
Harris, E. N., Gharavi, A. E., Asherson, R. A., Boey, M. L., and Hughes, G. R. V., 1984, Cerebral infarction in systemic lupus: Association with anticardiolipin antibodies, Clin. Exp. Rheum. 1: 47–51.
Harris, E. N., Asherson, R. A., Gharavi, A. E., Morgan, S. H., Derue, G., and Hughes, G. R. V., 1985a, Thrombocytopenia in SLE and related autoimmune disorders: Association with anticardiolipin antibody, Br. J. Haematol. 59: 227–230.
Harris, E. N., Gharavi, A. E., Hegde, V., Morgan, S. H., Derue, G., Englert, H., Chan, J. K. H., Asherson, R. A., and Hughes, G. R. V., 1985b, Anticardiolipin antibodies in autoimmune thrombocytopenic purpura, Br. J. Haematol. 59: 1–6.
Harris, E. N., Gharavi, A. E., Loizou, S., Derue, G., Chan, J. K., Patel, B. M., Mackworth-Young, C. G., Bunn, C. C., and Hughes, G. R. V., 1985c, Crossreactivity of antiphospholipid antibodies, J. Clin. Lab. Immunol. 16: 1–6.
Harvey, A. M., and Shulman, L. E., 1966, Connective tissue disease and chronic biologic false-positive test for syphilis (BFP reaction), Med. Clin. North Am. 50: 1271–1279.
Harvey, A. M., and Shulman, L. E., 1974, Systemic lupus erythematosus and the chronic biologic false- positive test for syphilis, in: Lupus Erythematosus, 2nd edition ( E. I. Dubois, ed.), University of California Press, Los Angeles, pp. 196–209.
Haserick, J. R., and Long, R., 1951, Systemic lupus erythematosus preceded by false-positive tests for syphilis: Presentation of five cases, Ann. Int. Med. 37: 559–565.
Hirano, T., Hashimoto, H., Shiokawa, Y., Iwamora, M., Nagai, Y., Kasai, M., and Ochiai, K., 1980, Antiglycolipid autoantibody detected in the sera from systemic lupus erythematosus patients, J. Clin. Invest. 66: 1437–1440.
Howard, M. A., and Firkin, B. G., 1983, Investigations of the lupus-like inhibitor bypassing activity of platelets, Thromb. Haemostas. (Stuttgart) 50: 775–779.
Hughes, G. R. V., 1983, Thrombosis, abortion, cerebral disease and the lupus anticoagulant, Br. Med. J. 287: 1088–1089.
Hull, R. G., Harris, E. N., Morgan, S. H., and Hughes, G. R. V., 1983, Anti-Ro antibodies and abortions in women with SLE, Lancet 2: 1138.
Inoue, K., and Nojima, S., 1967a, Immunochemical studies of phospholipids. I. Reactivity of various synthetic cardiolipin derivatives with Wasserman antibody, Chem. Phys. Lipids 1: 360–367.
Inoue, K., and Nojima, S., 1967b, Immunochemical studies of phospholipids II. Production of antibody to cardiolipin, Biochim. Biophys. Acta 144: 409–414.
Inoue, K., and Nojima, S., 1969, Immunochemical studies of phospholipids. IV: The reactivities of antisera against natural cardiolipin and synthetic cardiolipin analogues-containing antigens, Chem. Phys. Lipids 3: 70–77.
Johansson, E. A., and Lassus, A., 1974, The occurrence of circulating anticoagulants in patients with syphilitic and biologically false positive antilipoidal antibodies, Ann. Clin. Res. 6: 105–108.
Johansson, E. A., Lassus, A., and Salo, O. P., 1972, Occurrence of antinuclear factors with immunoglobulins bound to the dermo-epidermal junction in patients with chronic biological false positive (CBFP) reactions for syphilis, Acta Derm. Vener. (Stockholm) 52: 196–200.
Johansson, E. A., Niemi, K. M., and Mustakallio, K. K., 1977, A peripheral vascular syndrome overlapping with systemic lupus erythematosus: Recurrent venous thrombosis and hemorrhagic capillary proliferation with circulating anticoagulants and false-positive seroreactions for syphilis, Dermatologica 155: 257–267.
Koike, T., Tomioka, H., and Kumagai, A., 1982, Antibodies cross-reactive with DNA and cardiolipin in patients with systemic lupus erythematosus, Clin. Exp. Immunol. 50: 298–302.
Koike, T., Seuishi, M., Funaki, H., Tomioka, H., and Yoshida, S., 1984a, Antiphospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus, Clin. Exp. Immunol. 56: 193–199.
Koike, T., Maruyama, N., Funaki, H., Tomioka, H., and Yoshida, S., 1984b, Specificity of mouse hybridoma antibodies to DNA II. Phospholipid reactivity and biological false positive serological test for syphilis, Clin. Exp. Immunol. 57: 345–350.
Konstant, H., 1972, Familial chronic biologic false-positive seroreactions for syphilis: Report of two families, one with three generations affected, JAMA 219: 45–48.
Labro, M. T., Andrieu, M., Weber, M., and Homberg, J. C., 1978, A new pattern of non-organ and non- species-specific anti-organelle antibody detected by immunofluorescence: The mitochondrial antibody number 5, Clin. Exp. Immunol. 31: 357–366.
Lafer, E. M., Rauch, J., Andrzejewski, C., Mudd, D., Furie, B., Schwarz, R. S., and Stollar, B. D., 1981, Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids, J. Exp. Med. 153: 897–909.
Landi, G., Calloni, M. V., and Sabbadini, M. G., 1983, Recurrent ischemic attacks in young adults with lupus anticoagulant, Stroke 14: 377–379.
Laurell, A. B., and Nilsson, I. M., 1957, Hypergammaglobulinemia, circulating anticoagulant, and biologic false positive Wasserman reaction: A study of two cases, J. Lab. Clin. Med. 49: 694–707.
Lechner, K., 1969, A new type of coagulation inhibitor, Thromb. Diathes. Haemorrh. 21: 482–499.
Lechner, K., 1971, Acquired inhibitors in auto- and isoimmune disease, Thromb. Diathes. Haemorrh. (Suppl.) 45: 227–241.
Lechner, K., 1974, Acquired inhibitors in nonhemophilic patients, Haemostasis 3: 65–93.
Lee, S. L., and Miotti, A. B., 1975, Disorders of hemostatic function in patients with systemic lupus erythe-matosus, Semin. Arthritis Rheum. 4: 241–252.
Lee, S. L., and Sanders, M., 1955, A disorder of blood coagulation in systemic lupus erythematosus, J. Clin. Invest. 34: 1814–1822.
Loeliger, A., 1959, Prothrombin as cofactor of the circulating anticoagulant in systemic lupus erythematosus, Thromb. Diathes. Haemorrh. 3: 237–256.
Lubbe, W. F., Palmer, S. J., Butler, W. S., and Laggins, G. C., 1983, Fetal survival after prednisone suppression of maternal lupus anticoagulant, Lancet 1: 1361–1363.
MacFarlane, M. G., and Gray, G. M., 1957, Composition of cardiolipin, Biochem. J. 67: 25.
MacFarlane, M. G., and Wheeldon, L. W., 1958, Position of the fatty acids in cardiolipin, Nature 183: 1808.
Margolius, A., Jackson, D. P., and Ratnoff, O. D., 1961, Circulating anticoagulants: A study of 40 cases and a review of the literature, Medicine (Baltimore) 40: 145–202.
Medal, L. S., and Lisker, R., 1959, Circulating anticoagulants in disseminated lupus erythematosus, Br. J. Haematol. 5: 284–293.
Moore, J. E., and Lutz, W. B., 1955, The natural history of systemic lupus erythematosus: An approach to its study through chronic biologic false positive reactors, J Chron. Dis. 1: 297–316.
Moore, J. E., and Mohr, C. F., 1952, Biologically false positive serologic tests for syphilis: Type, incidence, and cause, JAMA 150: 467–473.
Morgan, A., Thompson, S., Rogers, L. A., and Staines, N. A., 1983, Specificity of murine monoclonal anti-DNA autoantibodies: Reactivity with nucleotides, nucleosides and phospholipids, British Society of Immunology Meeting, Spring 1983.
Mueh, J. R., Herbst, K. D., and Rapaport, S. I., 1980, Thrombosis in patients with the lupus anticoagulant, Ann. Intern. Med. 92: 156–159.
Nelson, R. A., and Mayer, M. M., 1949, Immobilization of treponema pallidum in vitro by antibody produced in syphilitic infection, J. Exp. Med. 89: 369.
Nelson, R. A., Zhuetlin, H. E. C., Diesendrick, J., and Austin, P. A., 1950, Studies on treponemal immobilizing antibodies in syphilis, Ann. J. Syph. Gonorr. Vener. Dis. 34: 101.
Nilsson, I. M., Astedt, B., Hedner, U., and Berezin, D., 1975, Intrauterine death and circulating anticoagulant (“antithromboplastin”), Acta. Med. Scand. 197: 159.
Pangborn, M. C., 1941, A new serologically active phospholipid from beef heart, Proc. Soc. Exp. Biol. 48: 484–486.
Prentice, R. L., Gatenby, P. A., Loblay, R. H., Shearman, R. P., Kronenberg, H., and Basten, A., 1984, Lupus anticoagulant in pregnancy, Lancet 1: 464.
Putkonen, T., Jokinen, E. J., and Mustakallio, K. K., 1967, Chronic biologic false positive seroreactions for syphilis as a harbinger of systemic lupus erythematosus, Arch Derm. Vener. 47: 83–88.
Rauch, J., Tannenbaum, H., Stollar, B. D., and Schwarz, R. S., 1984, Monoclonal anticardiolipin antibodies bind DNA, Eur. J. Immunol. 14: 529–534.
Ros, J. O., Tarres, M. V., Baucells, M. V., Maired, J. V., and Solano, J. T., 1983, Prednisone and maternal lupus anticoagulant, Lancet 2: 576.
Schleider, M. A., Nachman, R. L., Jaffe, E. A., and Coleman, M., 1976, A clinical study of the lupus anticoagulant, Blood 48: 499–509.
Shapiro, S. S., and Thiagarajan, P., 1982, Lupus anticoagulants, Prog. Hemostasis Thromb. 6: 263–285.
Shoenfeld, Y., Rauch, J., Massicotte, H., Datta, S. K., Andre-Schwarz, J., Stollar, B. D., and Schwarz, R. S., 1983, Poly specificity of monoclonal lupus autoantibodies produced by human-human hybridomas, N. Engl. J. Med. 308: 414–420.
Soulier, R. P., and Boffa, M. C., 1980, Avortements a repetition, thromboses et anticoagulant circulant antithromboplastine, Nouv. Presse Med. 9: 859–864.
Tamamura, S., Hashimoto, T., and Hara, I., 1971, The immunological relations between acidic phospholipids and their antibodies, Jpn. J. Exp. Med. 41: 31–38.
Teitelbaum, D., Arnon, R., Sela, M., Rabinsohn, Y., and Shapiro, D., 1973, Sphingomyelin specific antibodies elicited by synthetic conjugates, Immunochemistry 10: 736–743.
Thiagarajan, P., Shapiro, S. S., and De Marco, L., 1980, Monoclonal immunoglobulin M coagulation inhibitor with phospholipid specificity—mechanism of a lupus anticoagulant, J. Clin. Invest. 66: 397–405.
Tincani, A., Meroni, P. L., Mantelli, P. G., and Balestrieri, G., 1984, Anti-phospholipid antibodies: Their relationship with anti-DNA and anti-mitochondrial activity, ANA symposium, Leuven, Belgium.
Tuffanelli, D. L., 1968, False positive reactions for syphilis: Serological abnormalities in relatives of chronic reactors, Arch Dermatol. 98: 606–611.
Valesini, G., Carsetti, R., Patricelli, S., Conti, L., Grandolfo, G. M., and Nicotra, M., 1982, Autoimmunity and abortion, in: Serono Symposium No. 45. Immunological Factors in Human Reproduction ( S. Shulman, F. Dondero, and M. Nicotra, eds.), Academic Press, London, New York.
Veltkamp, J. J., Kerkhoven, P., and Loeliger, E. A., 1974, Circulating anticoagulant in disseminated lupus erythematosus: Proposed mode of action, Haemostasis 2: 253–259.
Weupper, K. D., Bodily, H. L., and Tuffanelli, D. L., 1966, Serologic tests for syphilis and the false-positive reactor, Arch. Dermatol. 94: 152–155.
Wicken, A. J., Gibbens, J. W., and Knox, K. W., 1972, Anti-techoic acid antibodies and non-treponemal serological tests for syphilis, Infect. Immun. 5: 982–984.
Williams, H., Laurent, R., and Gibson, T., 1980, The lupus coagulation inhibitor and venous thrombosis: A report of four cases, Clin. Lab. Haematol. 2: 139–144.
Wilson, H. A., Winfield, J. B., Lahita, R. G., and Koffler, D., 1979, The association of IgG anti-brain antibodies with central nervous system dysfunction and systemic lupus erythematosus, Arthritis Rheum. 12: 458–462.
Wilson, W. A., and Hughes, G. R. V., 1975, Aetiology of Jamaican neuropathy, Lancet 1: 240.
Wright, D. J. M., Doniach, D., Lessof, M. H., Turk, J. L., Grimble, A. S., and Catterall, R. D., 1970, New antibody in early syphilis, Lancet 1: 740–743.
Yin, E. T., and Gaston, L. W., 1965, Purification and kinetic studies on a circulating anticoagulant in a suspected case of lupus erythematosus, Thromb. Diathes. Haemostas. 14: 88–115.
Zvaifler, N. J., and Bluestein, H. G., 1982, The pathogenesis of central nervous system manifestations of systemic lupus erythematosus, Arthritis Rheum. 25: 862–866.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Plenum Publishing Corporation
About this chapter
Cite this chapter
Hughes, G.R.V., Harris, E.N., Gharavi, A.E. (1985). Antiphospholipid Antibodies. In: Gupta, S., Talal, N. (eds) Immunology of Rheumatic Diseases. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2493-5_10
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2493-5_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9509-9
Online ISBN: 978-1-4613-2493-5
eBook Packages: Springer Book Archive